Childhood neuroblastoma, a neuroendocrine tumour of the peripheral sympathetic nervous system, is associated with amplification of the MYCN oncogene and mutational activation of ALK (encoding anaplastic lymphoma kinase). Models that clarify whether and how these genes interact in the development of neuroblastoma are limited. Zhu et al. generated transgenic zebrafish overexpressing human MYCN and activated ALK, resulting in tumours that closely mimic those observed in the human disease. The authors show that MYCN over-expression alone causes aberrant neuroblast hyperplasia early during development, which is offset in part by a subsequent apoptotic event; surviving MYCN-over-expressing cells fail to differentiate and give rise to neuroblastoma. Co-expression of mutationally activated ALK blocks the apoptotic event but does not restore neuroblast differentiation, tripling penetrance and accelerating the onset of neuroblastoma. These results provide insight into the synergistic relationship between two important mediators of neuroblastoma, and could help in developing treatments for the disease.
MYCN and mutationally activated ALK synergise in neuroblastoma
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 May 2012
- Share Icon Share
-
Tools Icon
Tools
- Search Site
MYCN and mutationally activated ALK synergise in neuroblastoma. Dis Model Mech 1 May 2012; 5 (3): 287. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. The deadline for submitting articles to the special issue has been extended to 1 August 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists